These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25563708)

  • 21. Improvement of left atrial function is associated with lower incidence of atrial fibrillation and mortality after cardiac resynchronization therapy.
    Fung JW; Yip GW; Zhang Q; Fang F; Chan JY; Li CM; Wu LW; Chan GC; Chan HC; Yu CM
    Heart Rhythm; 2008 Jun; 5(6):780-6. PubMed ID: 18467188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pilot study to assess benefit of atrial rhythm control after cardiac resynchronization therapy and atrioventricular node ablation.
    Schwartzman D; Housel D; Bazaz R; Jain S; Saba S; Gorcsan J; Adelstein E
    Pacing Clin Electrophysiol; 2015 Feb; 38(2):275-81. PubMed ID: 25431023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac resynchronization therapy response is associated with shorter duration of atrial fibrillation.
    Lellouche N; De Diego C; Vaseghi M; Buch E; Cesario DA; Mahajan A; Wiener I; Fonarow GC; Boyle NG; Shivkumar K
    Pacing Clin Electrophysiol; 2007 Nov; 30(11):1363-8. PubMed ID: 17976100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of cardiac resynchronization on the incidence of atrial fibrillation in patients with severe heart failure.
    Hoppe UC; Casares JM; Eiskjaer H; Hagemann A; Cleland JG; Freemantle N; Erdmann E
    Circulation; 2006 Jul; 114(1):18-25. PubMed ID: 16801461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial.
    Brignole M; Botto G; Mont L; Iacopino S; De Marchi G; Oddone D; Luzi M; Tolosana JM; Navazio A; Menozzi C
    Eur Heart J; 2011 Oct; 32(19):2420-9. PubMed ID: 21606084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atrial fibrillation burden and subsequent heart failure events in patients with cardiac resynchronization therapy devices.
    Tanawuttiwat T; Lande J; Smeets P; Gerritse B; Nazarian S; Guallar E; Cheng A
    J Cardiovasc Electrophysiol; 2020 Jun; 31(6):1519-1526. PubMed ID: 32162753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of atrial fibrillation on early complications and one year-survival after cardioverter defibrillator implantation: results from the German DEVICE registry.
    Köbe J; Wasmer K; Andresen D; Kleemann T; Spitzer SG; Jehle J; Brachmann J; Stellbrink C; Hochadel M; Senges J; Klein HU; Eckardt L
    Int J Cardiol; 2013 Oct; 168(4):4184-90. PubMed ID: 23948108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The epidemic of inadequate biventricular pacing in patients with persistent or permanent atrial fibrillation and its association with mortality.
    Ousdigian KT; Borek PP; Koehler JL; Heywood JT; Ziegler PD; Wilkoff BL
    Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):370-6. PubMed ID: 24838004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early detection of atrial high rate episodes predicts atrial fibrillation and thromboembolic events in patients with cardiac resynchronization therapy.
    Witt CT; Kronborg MB; Nohr EA; Mortensen PT; Gerdes C; Nielsen JC
    Heart Rhythm; 2015 Dec; 12(12):2368-75. PubMed ID: 26164377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increase of ventricular interval during atrial fibrillation by atrioventricular node vagal stimulation: chronic clinical atrioventricular-nodal stimulation download study.
    Bianchi S; Rossi P; Schauerte P; Elvan A; Blomström-Lundqvist C; Kornet L; Gal P; Mörtsell D; Wouters G; Gemein C
    Circ Arrhythm Electrophysiol; 2015 Jun; 8(3):562-8. PubMed ID: 25878323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of paroxysmal atrial tachycardias in patients treated with cardiac resynchronization therapy and continuously monitored by device diagnostics.
    Leclercq C; Padeletti L; Cihák R; Ritter P; Milasinovic G; Gras D; Paul V; Van Gelder IC; Stellbrink C; Rieger G; Corbucci G; Albers B; Daubert JC;
    Europace; 2010 Jan; 12(1):71-7. PubMed ID: 19864311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter.
    Ahmari SA; Bunch TJ; Chandra A; Chandra V; Ujino K; Daly RC; Kushwaha SS; Edwards BS; Maalouf YF; Seward JB; McGregor CG; Chandrasekaran K
    J Heart Lung Transplant; 2006 Jan; 25(1):53-60. PubMed ID: 16399531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical importance of new-onset atrial fibrillation after cardiac resynchronization therapy.
    Borleffs CJ; Ypenburg C; van Bommel RJ; Delgado V; van Erven L; Schalij MJ; Bax JJ
    Heart Rhythm; 2009 Mar; 6(3):305-10. PubMed ID: 19251202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atrioventricular nodal ablation in patients with resynchronization therapy and atrial fibrillation - long term results.
    Aune A; Færestrand S; Hoff PI; Schuster P
    Scand Cardiovasc J; 2017 Jun; 51(3):138-142. PubMed ID: 28345365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of life in cardiac resynchronization recipients: association with response and impact on outcome.
    Lenarczyk R; Jędrzejczyk-Patej E; Mazurek M; Szulik M; Kowalski O; Pruszkowska P; Sokal A; Średniawa B; Boidol J; Kowalczyk J; Podolecki T; Mencel G; Kalarus Z
    Pacing Clin Electrophysiol; 2015 Jan; 38(1):8-17. PubMed ID: 25319879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized controlled trial of atrioventricular junction ablation and cardiac resynchronization therapy in patients with permanent atrial fibrillation and narrow QRS.
    Brignole M; Pokushalov E; Pentimalli F; Palmisano P; Chieffo E; Occhetta E; Quartieri F; Calò L; Ungar A; Mont L;
    Eur Heart J; 2018 Dec; 39(45):3999-4008. PubMed ID: 30165479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of atrial fibrillation detected by continuous rhythm monitoring after acute myocardial infarction in patients with preserved left ventricular ejection fraction: results of the ARREST study.
    Romanov A; Martinek M; Pürerfellner H; Chen S; De Melis M; Grazhdankin I; Ponomarev D; Losik D; Strelnikov A; Shabanov V; Karaskov A; Pokushalov E
    Europace; 2018 Feb; 20(2):263-270. PubMed ID: 28069838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atrial Fibrillation During Cardiac Resynchronization Therapy.
    Kloosterman M; Maass AH; Rienstra M; Van Gelder IC
    Card Electrophysiol Clin; 2015 Dec; 7(4):735-48. PubMed ID: 26596815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Many response criteria are poor predictors of outcomes after cardiac resynchronization therapy: validation using data from the randomized trial.
    Boidol J; Średniawa B; Kowalski O; Szulik M; Mazurek M; Sokal A; Pruszkowska-Skrzep P; Kukulski T; Kalarus Z; Lenarczyk R;
    Europace; 2013 Jun; 15(6):835-44. PubMed ID: 23487543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of benefits and mortality in cardiac resynchronization therapy in patients with atrial fibrillation versus patients in sinus rhythm (Results of the Spanish Atrial Fibrillation and Resynchronization [SPARE] Study).
    Tolosana JM; Hernandez Madrid A; Brugada J; Sitges M; Garcia Bolao I; Fernandez Lozano I; Martinez Ferrer J; Quesada A; Macias A; Marin W; Escudier JM; Gomez AA; Gimenez Alcala M; Tamborero D; Berruezo A; Mont L;
    Am J Cardiol; 2008 Aug; 102(4):444-9. PubMed ID: 18678303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.